Ilkka Kantola
Professor; Head of Medical Division, Turku university Hospital
ilkkan@utu.fi ORCID identifier: https://orcid.org/0000-0002-6228-522X |
Areas of expertise
Hypertensio;Fabry disease; diabetes mellitus; sleep apnea
Hypertensio;Fabry disease; diabetes mellitus; sleep apnea
Publications
- Clinical outcomes in patients switching from agalsidase beta to migalastat : A Fabry Registry analysis (2024)
- Journal of Inherited Metabolic Disease
(A1 Refereed original research article in a scientific journal) - Hemodynamic Bedside Monitoring Instrument with Pressure and Optical Sensors : Validation and Modality Comparison (2024)
- Advanced Science
(A1 Refereed original research article in a scientific journal) - Hypertensio: primaarinen hypertensio (2024) Kardiologia Kantola, Ilkka; Niiranen, Teemu
(D2 Article in a professional compilation book) - Management of patients with hypertension and chronic kidney disease referred to Hypertension Excellence Centres among 27 countries. On behalf of the European Society of Hypertension Working Group on Hypertension and the Kidney (2024)
- Blood Pressure
(A1 Refereed original research article in a scientific journal) - Screening and management of hypertensive patients with chronic kidney disease referred to Hypertension Excellence Centres among 27 countries. A pilot survey based on questionnaire (2024)
- Journal of Hypertension
(A1 Refereed original research article in a scientific journal) - Verenpainetaudin lääkehoito yksilöllistyy (2024)
- Lääkärilehti
(A2 Refereed review article in a scientific journal ) - An expert consensus on the recommendations for the use of biomarkers in Fabry disease (2023)
- Molecular Genetics and Metabolism
(A2 Refereed review article in a scientific journal ) - Chronic kidney disease stage is associated with the number of risk factors in type 2 diabetes patients (STages Of NEphropathy in type 2 diabetes and Heart Failure - STONE HF) (2023)
- Primary Care Diabetes
(A1 Refereed original research article in a scientific journal) - Clinical outcomes among young patients with Fabry disease who initiated agalsidase beta treatment before 30 years of age: An analysis from the Fabry Registry (2023)
- Molecular Genetics and Metabolism
(A1 Refereed original research article in a scientific journal) - Development and clinical validation of a miniaturized finger probe for bedside hemodynamic monitoring (2023)
- iScience
(A1 Refereed original research article in a scientific journal) - Fabryn tauti (2023) Reumasairaudet Kantola Ilkka
(D2 Article in a professional compilation book) - Head-to-head trial of pegunigalsidase alfa versus agalsidase beta in patients with Fabry disease and deteriorating renal function: results from the 2-year randomised phase III BALANCE study (2023)
- Journal of Medical Genetics
(A1 Refereed original research article in a scientific journal) - Late-onset and classic phenotypes of Fabry disease in males with the GLA-Thr410Ala mutation (2023)
- Open Heart
(A1 Refereed original research article in a scientific journal) - Long-term effectiveness of enzyme replacement therapy in Fabry disease with the p.Arg227Ter variant: Fabry disease in Ostrobothnia (FAST) study (2023)
- American Journal of Medical Genetics Part A
(A1 Refereed original research article in a scientific journal) - Identifying and treating resistant hypertension in PRECISION: A randomized long-term clinical trial with aprocitentan (2022)
- Journal of Clinical Hypertension
(A1 Refereed original research article in a scientific journal) - Pulmonary manifestations and the effectiveness of enzyme replacement therapy in Fabry Disease with the p. Arg227Ter (p.R227*) mutation (2022)
- Molecular Genetics and Genomic Medicine
(A1 Refereed original research article in a scientific journal) - THE CHANGE IN QUALITY OF LIFE IN DRUG TREATED HYPERTENSIVE PATIENTS AFTER 10 YEARS OF ANTIHYPERTENSIVE TREATMENT (2022)
- Journal of Hypertension
(Other publication) - The majority of type 2 diabetic patients in Finnish primary care are at very high risk of cardiovascular events: A cross-sectional chart review study (STONE HF) (2022)
- Primary Care Diabetes
(A1 Refereed original research article in a scientific journal) - Verenpainetaudin, sepelvaltimotaudin ja sydämen vajaatoiminnan lääkehoito (2022) Farmakologia ja toksikologia Kantola Ilkka, Mervaala Eero
(D2 Article in a professional compilation book) - An instrument for measuring blood pressure and assessing cardiovascular health from the fingertip (2020)
- Biosensors and Bioelectronics
(A1 Refereed original research article in a scientific journal)